Predictive Oncology Inc. (NASDAQ: POAI)
$1.13
+0.0150 ( +1.35% ) 51.8K
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
Market Data
Open
$1.13
Previous close
$1.11
Volume
51.8K
Market cap
$4.68M
Day range
$1.10 - $1.15
52 week range
$0.89 - $7.12
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | May 30, 2024 |
8-k | 8K-related | 15 | May 15, 2024 |
10-q | Quarterly Reports | 68 | May 14, 2024 |
8-k | 8K-related | 14 | May 06, 2024 |
4 | Insider transactions | 1 | Apr 12, 2024 |
4 | Insider transactions | 1 | Apr 12, 2024 |
4 | Insider transactions | 1 | Apr 12, 2024 |
4 | Insider transactions | 1 | Apr 12, 2024 |
4 | Insider transactions | 1 | Apr 12, 2024 |
4 | Insider transactions | 1 | Apr 12, 2024 |